Dr. Justin GU joined Laekna, Inc. (“Laekna”) in 2020 as Chief Scientific Officer responsible for overseeing Group’s pre-clinical discovery research works. He was appointed as an executive Director in May 2022. 

Dr. GU has over 20 years of experience in the biotechnology and pharmaceutical industry. Before joining Laekna, Dr. GU was a venture partner at GP Healthcare Capital Co., Ltd. in 2019. 

Dr. GU worked at Novartis for 18 years. From 2001 to 2008, he served as a scientist and a group leader at Genomics Institute of the Novartis Research Foundation (GNF) in San Diego, USA. In 2008, Dr. GU returned to China and joined the newly established China Novartis Institute for Biomedical Research (CNIBR), first served as an investigator and then as the director of the lead discovery department.

Dr. GU received his Bachelor’s degree in biology from Nankai University in China; Master’s degree from the Institute of Botany, The Chinese Academy of Sciences; and the Doctor of Philosophy degree in biochemistry from the Ohio State University in the United States. Before entering the pharma industry, Dr. GU worked at Massachusetts Institute of Technology for three years as a postdoctoral fellow.